相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia
Leopold Garnar-Wortzel et al.
ACS CENTRAL SCIENCE (2021)
Discovery of Selective Small-Molecule Inhibitors for the ENL YEATS Domain
Xinyu R. Ma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
New paradigms on hematopoietic stem cell differentiation
Hui Cheng et al.
PROTEIN & CELL (2020)
Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia
Szymon Klossowski et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Impaired cell fate through gain-of-function mutations in a chromatin reader
Liling Wan et al.
NATURE (2020)
Cell-Based Ligand Discovery for the ENL YEATS Domain
Joshua N. Asiaban et al.
ACS CHEMICAL BIOLOGY (2020)
NPM1-mutated acute myeloid leukemia: from bench to bedside
Brunangelo Falini et al.
BLOOD (2020)
Combinatorial treatment with menin and FLT3 inhibitors induces complete remission in AML models with activating FLT3 mutations
Hongzhi Miao et al.
BLOOD (2020)
DOT1L-controlled cell-fate determination and transcription elongation are independent of H3K79 methylation
Kaixiang Cao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Selective Targeting of AF9 YEATS Domain by Cyclopeptide Inhibitors with Preorganized Conformation
Yixiang Jiang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads
Yang Liao et al.
NUCLEIC ACIDS RESEARCH (2019)
CRISPR-suppressor scanning reveals a nonenzymatic role of LSD1 in AML
Michael E. Vinyard et al.
NATURE CHEMICAL BIOLOGY (2019)
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Ann Lin et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment
Vincenzo Calvanese et al.
NATURE (2019)
Targeting non-bromodomain chromatin readers
Cheryl H. Arrowsmith et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2019)
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged Leukemia
Andrei V. Krivtsov et al.
CANCER CELL (2019)
Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9
Thomas Christott et al.
SLAS DISCOVERY (2019)
The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
Hamid Bolouri et al.
NATURE MEDICINE (2018)
Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer
Chih-Chao Hsu et al.
GENES & DEVELOPMENT (2018)
LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia
Yusuke Tarumoto et al.
MOLECULAR CELL (2018)
Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells
Jeremy D. Grevet et al.
SCIENCE (2018)
Gas41 links histone acetylation to H2A.Z deposition and maintenance of embryonic stem cell identity
Chih-Chao Hsu et al.
CELL DISCOVERY (2018)
Discovery of an MLLT1/3 YEATS Domain Chemical Probe
Moses Moustakim et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Structure-guided development of YEATS domain inhibitors by targeting pi-pi-pi stacking
Xin Li et al.
NATURE CHEMICAL BIOLOGY (2018)
Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration
James M. McFarland et al.
NATURE COMMUNICATIONS (2018)
YEATS Domain-A Histone Acylation Reader in Health and Disease
Dan Zhao et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Transcription control by the ENL YEATS domain in acute leukaemia
Michael A. Erb et al.
NATURE (2017)
ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia
Liling Wan et al.
NATURE (2017)
A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor
Samantha Gadd et al.
NATURE GENETICS (2017)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
Rapid generation of drug-resistance alleles at endogenous loci using CRISPR-Cas9 indel mutagenesis
Jonathan J. Ipsaro et al.
PLOS ONE (2017)
YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer
Wenyi Mi et al.
NATURE COMMUNICATIONS (2017)
MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches
Amanda C. Winters et al.
FRONTIERS IN PEDIATRICS (2017)
Creation of Novel Protein Variants with CRISPR/Cas9-Mediated Mut agenesis: Turning a Screening By-Product into a Discovery Tool
Katherine F. Donovan et al.
PLOS ONE (2017)
YEATS2 is a selective histone crotonylation reader
Dan Zhao et al.
CELL RESEARCH (2016)
Molecular Coupling of Histone Crotonylation and Active Transcription by AF9 YEATS Domain
Yuanyuan Li et al.
MOLECULAR CELL (2016)
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench et al.
NATURE BIOTECHNOLOGY (2016)
Near-optimal probabilistic RNA-seq quantification
Nicolas L. Bray et al.
NATURE BIOTECHNOLOGY (2016)
The Taf14 YEATS domain is a reader of histone crotonylation
Forest H. Andrews et al.
NATURE CHEMICAL BIOLOGY (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia
Michael W. M. Kuhn et al.
CANCER DISCOVERY (2016)
Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo
Dmitry Borkin et al.
CANCER CELL (2015)
Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force Field
Lingle Wang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
ngs.plot: Quick mining and visualization of next-generation sequencing data by integrating genomic databases
Li Shen et al.
BMC GENOMICS (2014)
AF9 YEATS Domain Links Histone Acetylation to DOT1L-Mediated H3K79 Methylation
Yuanyuan Li et al.
CELL (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
deepTools: a flexible platform for exploring deep-sequencing data
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
Scott R. Daigle et al.
BLOOD (2013)
SLAM Family Markers Resolve Functionally Distinct Subpopulations of Hematopoietic Stem Cells and Multipotent Progenitors
Hideyuki Oguro et al.
CELL STEM CELL (2013)
Impact of Physicochemical Profiling for Rational Approach on Drug Discovery
Shoko Nakashima et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2013)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cancer Epigenetics: From Mechanism to Therapy
Mark A. Dawson et al.
CELL (2012)
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia
Jolanta Grembecka et al.
NATURE CHEMICAL BIOLOGY (2012)
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Scott R. Daigle et al.
CANCER CELL (2011)
MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Kathrin M. Bernt et al.
CANCER CELL (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber et al.
NATURE (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes
Debabrata Biswas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin
Nanhai He et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
BEDTools: a flexible suite of utilities for comparing genomic features
Aaron R. Quinlan et al.
BIOINFORMATICS (2010)
A Higher-Order Complex Containing AF4 and ENL Family Proteins with P-TEFb Facilitates Oncogenic and Physiologic MLL-Dependent Transcription
Akihiko Yokoyama et al.
CANCER CELL (2010)
The Human PAF1 Complex Acts in Chromatin Transcription Elongation Both Independently and Cooperatively with SII/TFIIS
Jaehoon Kim et al.
CELL (2010)
AFF4, a Component of the ELL/P-TEFb Elongation Complex and a Shared Subunit of MLL Chimeras, Can Link Transcription Elongation to Leukemia
Chengqi Lin et al.
MOLECULAR CELL (2010)
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
Sven Heinz et al.
MOLECULAR CELL (2010)
Suppression of inflammation by a synthetic histone mimic
Edwige Nicodeme et al.
NATURE (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
YEATS domain proteins: a diverse family with many links to chromatin modification and transcription
Julia M. Schulze et al.
BIOCHEMISTRY AND CELL BIOLOGY (2009)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem Cells
Tim C. P. Somervaille et al.
CELL STEM CELL (2009)
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
Ben Langmead et al.
GENOME BIOLOGY (2009)
Menin critically links MLL proteins with LEDGE on cancer-associated target genes
Akihiko Yokoyama et al.
CANCER CELL (2008)
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F. Schlenk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Model-based Analysis of ChIP-Seq (MACS)
Yong Zhang et al.
GENOME BIOLOGY (2008)
A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification
Dorothee Mueller et al.
BLOOD (2007)
RNA polymerase is poised for activation across the genome
Ginger W. Muse et al.
NATURE GENETICS (2007)
MLL translocations, histone modifications and leukaemia stem-cell development
Andrei V. Krivtsov et al.
NATURE REVIEWS CANCER (2007)
Elucidation of the phenotypic, functional, and molecular topography of a myeloerythroid progenitor cell hierarchy
Cornelis J. H. Pronk et al.
CELL STEM CELL (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis
A Yokoyama et al.
CELL (2005)
Transcriptional networks in developing and mature B cells
P Matthias et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
B Falini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
